FDA to weigh easing limits on unproven peptides RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning Letters MedShadow Foundation